nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—Otitis—Octreotide—thymus cancer	0.0756	0.0756	CcSEcCtD
Atazanavir—Hepatic steatosis—Octreotide—thymus cancer	0.0434	0.0434	CcSEcCtD
Atazanavir—Ear infection—Octreotide—thymus cancer	0.0309	0.0309	CcSEcCtD
Atazanavir—Renal pain—Octreotide—thymus cancer	0.025	0.025	CcSEcCtD
Atazanavir—Cholecystitis—Octreotide—thymus cancer	0.0228	0.0228	CcSEcCtD
Atazanavir—Cholelithiasis—Octreotide—thymus cancer	0.0211	0.0211	CcSEcCtD
Atazanavir—Nail disorder—Octreotide—thymus cancer	0.0202	0.0202	CcSEcCtD
Atazanavir—Peptic ulcer—Octreotide—thymus cancer	0.0196	0.0196	CcSEcCtD
Atazanavir—Menstrual disorder—Octreotide—thymus cancer	0.0192	0.0192	CcSEcCtD
Atazanavir—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.0192	0.0192	CcSEcCtD
Atazanavir—Burning sensation—Octreotide—thymus cancer	0.0189	0.0189	CcSEcCtD
Atazanavir—Cholestasis—Octreotide—thymus cancer	0.0173	0.0173	CcSEcCtD
Atazanavir—Nephrolithiasis—Octreotide—thymus cancer	0.0163	0.0163	CcSEcCtD
Atazanavir—Amenorrhoea—Octreotide—thymus cancer	0.0149	0.0149	CcSEcCtD
Atazanavir—Cellulitis—Octreotide—thymus cancer	0.0144	0.0144	CcSEcCtD
Atazanavir—Oropharyngeal pain—Octreotide—thymus cancer	0.0144	0.0144	CcSEcCtD
Atazanavir—Hyperbilirubinaemia—Octreotide—thymus cancer	0.0144	0.0144	CcSEcCtD
Atazanavir—Drug interaction—Octreotide—thymus cancer	0.0141	0.0141	CcSEcCtD
Atazanavir—Muscle twitching—Octreotide—thymus cancer	0.0134	0.0134	CcSEcCtD
Atazanavir—Wheezing—Octreotide—thymus cancer	0.0127	0.0127	CcSEcCtD
Atazanavir—Urine output increased—Octreotide—thymus cancer	0.0119	0.0119	CcSEcCtD
Atazanavir—Mouth ulceration—Octreotide—thymus cancer	0.0119	0.0119	CcSEcCtD
Atazanavir—Gynaecomastia—Octreotide—thymus cancer	0.0117	0.0117	CcSEcCtD
Atazanavir—Hyperkinesia—Octreotide—thymus cancer	0.0114	0.0114	CcSEcCtD
Atazanavir—Sleep disorder—Octreotide—thymus cancer	0.011	0.011	CcSEcCtD
Atazanavir—Diabetes mellitus—Octreotide—thymus cancer	0.0109	0.0109	CcSEcCtD
Atazanavir—Polyuria—Octreotide—thymus cancer	0.0108	0.0108	CcSEcCtD
Atazanavir—Gastroenteritis—Octreotide—thymus cancer	0.0107	0.0107	CcSEcCtD
Atazanavir—Nasal congestion—Octreotide—thymus cancer	0.0105	0.0105	CcSEcCtD
Atazanavir—Amnesia—Octreotide—thymus cancer	0.0101	0.0101	CcSEcCtD
Atazanavir—Hypoglycaemia—Octreotide—thymus cancer	0.00976	0.00976	CcSEcCtD
Atazanavir—Pain in extremity—Octreotide—thymus cancer	0.00952	0.00952	CcSEcCtD
Atazanavir—Psychotic disorder—Octreotide—thymus cancer	0.0093	0.0093	CcSEcCtD
Atazanavir—Dehydration—Octreotide—thymus cancer	0.00886	0.00886	CcSEcCtD
Atazanavir—Dry skin—Octreotide—thymus cancer	0.00873	0.00873	CcSEcCtD
Atazanavir—Nasopharyngitis—Octreotide—thymus cancer	0.00852	0.00852	CcSEcCtD
Atazanavir—Gastritis—Octreotide—thymus cancer	0.00843	0.00843	CcSEcCtD
Atazanavir—Muscular weakness—Octreotide—thymus cancer	0.0084	0.0084	CcSEcCtD
Atazanavir—Abdominal distension—Octreotide—thymus cancer	0.00829	0.00829	CcSEcCtD
Atazanavir—Pancreatitis—Octreotide—thymus cancer	0.00807	0.00807	CcSEcCtD
Atazanavir—Pollakiuria—Octreotide—thymus cancer	0.0076	0.0076	CcSEcCtD
Atazanavir—Weight increased—Octreotide—thymus cancer	0.00749	0.00749	CcSEcCtD
Atazanavir—Weight decreased—Octreotide—thymus cancer	0.00745	0.00745	CcSEcCtD
Atazanavir—Hyperglycaemia—Octreotide—thymus cancer	0.00743	0.00743	CcSEcCtD
Atazanavir—Depression—Octreotide—thymus cancer	0.00732	0.00732	CcSEcCtD
Atazanavir—Neuropathy peripheral—Octreotide—thymus cancer	0.00719	0.00719	CcSEcCtD
Atazanavir—Jaundice—Octreotide—thymus cancer	0.00715	0.00715	CcSEcCtD
Atazanavir—Urinary tract infection—Octreotide—thymus cancer	0.00713	0.00713	CcSEcCtD
Atazanavir—Haematuria—Octreotide—thymus cancer	0.007	0.007	CcSEcCtD
Atazanavir—Hepatobiliary disease—Octreotide—thymus cancer	0.00694	0.00694	CcSEcCtD
Atazanavir—Hepatitis—Octreotide—thymus cancer	0.00659	0.00659	CcSEcCtD
Atazanavir—Hypoaesthesia—Octreotide—thymus cancer	0.00656	0.00656	CcSEcCtD
Atazanavir—Oedema peripheral—Octreotide—thymus cancer	0.00649	0.00649	CcSEcCtD
Atazanavir—Tinnitus—Octreotide—thymus cancer	0.00614	0.00614	CcSEcCtD
Atazanavir—Cardiac disorder—Octreotide—thymus cancer	0.00611	0.00611	CcSEcCtD
Atazanavir—Immune system disorder—Octreotide—thymus cancer	0.00595	0.00595	CcSEcCtD
Atazanavir—Alopecia—Octreotide—thymus cancer	0.00582	0.00582	CcSEcCtD
Atazanavir—Mental disorder—Octreotide—thymus cancer	0.00577	0.00577	CcSEcCtD
Atazanavir—Malnutrition—Octreotide—thymus cancer	0.00574	0.00574	CcSEcCtD
Atazanavir—Flatulence—Octreotide—thymus cancer	0.00565	0.00565	CcSEcCtD
Atazanavir—Tension—Octreotide—thymus cancer	0.00563	0.00563	CcSEcCtD
Atazanavir—Nervousness—Octreotide—thymus cancer	0.00557	0.00557	CcSEcCtD
Atazanavir—Back pain—Octreotide—thymus cancer	0.00555	0.00555	CcSEcCtD
Atazanavir—Ill-defined disorder—Octreotide—thymus cancer	0.00532	0.00532	CcSEcCtD
Atazanavir—Agitation—Octreotide—thymus cancer	0.00527	0.00527	CcSEcCtD
Atazanavir—Malaise—Octreotide—thymus cancer	0.00517	0.00517	CcSEcCtD
Atazanavir—Syncope—Octreotide—thymus cancer	0.00514	0.00514	CcSEcCtD
Atazanavir—Palpitations—Octreotide—thymus cancer	0.00507	0.00507	CcSEcCtD
Atazanavir—Loss of consciousness—Octreotide—thymus cancer	0.00504	0.00504	CcSEcCtD
Atazanavir—Cough—Octreotide—thymus cancer	0.005	0.005	CcSEcCtD
Atazanavir—Convulsion—Octreotide—thymus cancer	0.00497	0.00497	CcSEcCtD
Atazanavir—Hypertension—Octreotide—thymus cancer	0.00495	0.00495	CcSEcCtD
Atazanavir—Arthralgia—Octreotide—thymus cancer	0.00488	0.00488	CcSEcCtD
Atazanavir—Chest pain—Octreotide—thymus cancer	0.00488	0.00488	CcSEcCtD
Atazanavir—Myalgia—Octreotide—thymus cancer	0.00488	0.00488	CcSEcCtD
Atazanavir—Anxiety—Octreotide—thymus cancer	0.00487	0.00487	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00485	0.00485	CcSEcCtD
Atazanavir—Discomfort—Octreotide—thymus cancer	0.00482	0.00482	CcSEcCtD
Atazanavir—Dry mouth—Octreotide—thymus cancer	0.00478	0.00478	CcSEcCtD
Atazanavir—Oedema—Octreotide—thymus cancer	0.00468	0.00468	CcSEcCtD
Atazanavir—Infection—Octreotide—thymus cancer	0.00465	0.00465	CcSEcCtD
Atazanavir—Shock—Octreotide—thymus cancer	0.00461	0.00461	CcSEcCtD
Atazanavir—Nervous system disorder—Octreotide—thymus cancer	0.00459	0.00459	CcSEcCtD
Atazanavir—Skin disorder—Octreotide—thymus cancer	0.00455	0.00455	CcSEcCtD
Atazanavir—Hyperhidrosis—Octreotide—thymus cancer	0.00453	0.00453	CcSEcCtD
Atazanavir—Anorexia—Octreotide—thymus cancer	0.00446	0.00446	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00426	0.00426	CcSEcCtD
Atazanavir—Insomnia—Octreotide—thymus cancer	0.00423	0.00423	CcSEcCtD
Atazanavir—Dyspnoea—Octreotide—thymus cancer	0.00417	0.00417	CcSEcCtD
Atazanavir—Somnolence—Octreotide—thymus cancer	0.00416	0.00416	CcSEcCtD
Atazanavir—Dyspepsia—Octreotide—thymus cancer	0.00412	0.00412	CcSEcCtD
Atazanavir—Decreased appetite—Octreotide—thymus cancer	0.00407	0.00407	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Octreotide—thymus cancer	0.00404	0.00404	CcSEcCtD
Atazanavir—Fatigue—Octreotide—thymus cancer	0.00404	0.00404	CcSEcCtD
Atazanavir—Constipation—Octreotide—thymus cancer	0.004	0.004	CcSEcCtD
Atazanavir—Pain—Octreotide—thymus cancer	0.004	0.004	CcSEcCtD
Atazanavir—Feeling abnormal—Octreotide—thymus cancer	0.00386	0.00386	CcSEcCtD
Atazanavir—Gastrointestinal pain—Octreotide—thymus cancer	0.00383	0.00383	CcSEcCtD
Atazanavir—Urticaria—Octreotide—thymus cancer	0.00372	0.00372	CcSEcCtD
Atazanavir—Body temperature increased—Octreotide—thymus cancer	0.0037	0.0037	CcSEcCtD
Atazanavir—Abdominal pain—Octreotide—thymus cancer	0.0037	0.0037	CcSEcCtD
Atazanavir—Hypersensitivity—Octreotide—thymus cancer	0.00345	0.00345	CcSEcCtD
Atazanavir—Asthenia—Octreotide—thymus cancer	0.00336	0.00336	CcSEcCtD
Atazanavir—Pruritus—Octreotide—thymus cancer	0.00331	0.00331	CcSEcCtD
Atazanavir—Diarrhoea—Octreotide—thymus cancer	0.0032	0.0032	CcSEcCtD
Atazanavir—Dizziness—Octreotide—thymus cancer	0.0031	0.0031	CcSEcCtD
Atazanavir—Vomiting—Octreotide—thymus cancer	0.00298	0.00298	CcSEcCtD
Atazanavir—Rash—Octreotide—thymus cancer	0.00295	0.00295	CcSEcCtD
Atazanavir—Dermatitis—Octreotide—thymus cancer	0.00295	0.00295	CcSEcCtD
Atazanavir—Headache—Octreotide—thymus cancer	0.00293	0.00293	CcSEcCtD
Atazanavir—Nausea—Octreotide—thymus cancer	0.00278	0.00278	CcSEcCtD
